Swiss Institute for Experimental Cancer Research, School of Life Sciences, Swiss Federal Institute of Technology Lausanne, 1015 Lausanne, Switzerland.
Swiss Cancer Center Leman, 1015 Lausanne, Switzerland.
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24184-24195. doi: 10.1073/pnas.1913307116. Epub 2019 Nov 8.
MicroRNA-mediated gene regulation has been implicated in various diseases, including cancer. This study examined the role of microRNAs (miRNAs) during tumorigenesis and malignant progression of pancreatic neuroendocrine tumors (PanNETs) in a genetically engineered mouse model. Previously, a set of miRNAs was observed to be specifically up-regulated in a highly invasive and metastatic subtype of mouse and human PanNET. Using functional assays, we now implicate different miRNAs in distinct phenotypes: miR-137 stimulates tumor growth and local invasion, whereas the miR-23b cluster enables metastasis. An algorithm, Bio-miRTa, has been developed to facilitate the identification of biologically relevant miRNA target genes and applied to these miRNAs. We show that a top-ranked miR-137 candidate gene, , has a tumor suppressor function in primary PanNETs. Among the top targets for the miR-23b cluster, has recently been described to be a metastasis suppressor, and we establish herein that it is down-regulated by the miR-23b cluster, which is crucial for its prometastatic activity. Two other miR-23b targets, and , also have demonstrable antimetastatic effects. Finally, we have used the Bio-miRTa algorithm in reverse to identify candidate miRNAs that might regulate activin B, the principal ligand for ALK7, identifying thereby a third family of miRNAs-miRNA-130/301-that is congruently up-regulated concomitant with down-regulation of activin B during tumorigenesis, suggestive of functional involvement in evasion of the proapoptotic barrier. Thus, dynamic up-regulation of miRNAs during multistep tumorigenesis and malignant progression serves to down-regulate distinctive suppressor mechanisms of tumor growth, invasion, and metastasis.
microRNA 介导的基因调控与多种疾病有关,包括癌症。本研究在遗传工程小鼠模型中研究了 microRNAs(miRNAs)在胰腺神经内分泌肿瘤(PanNET)发生和恶性进展中的作用。此前,观察到一组 miRNAs 在小鼠和人类 PanNET 的一种高度侵袭性和转移性亚型中特异性上调。通过功能测定,我们现在将不同的 miRNAs 牵连到不同的表型中:miR-137 刺激肿瘤生长和局部侵袭,而 miR-23b 簇则促进转移。已经开发了一种算法 Bio-miRTa,以促进识别生物学上相关的 miRNA 靶基因,并将其应用于这些 miRNAs。我们表明,miR-137 的一个排名最高的候选基因 ,在原发性 PanNET 中具有肿瘤抑制功能。在 miR-23b 簇的顶级靶标中,最近已被描述为转移抑制因子,我们在此证明它被 miR-23b 簇下调,这对其促转移活性至关重要。miR-23b 簇的另外两个靶标 和 也具有明显的抗转移作用。最后,我们使用 Bio-miRTa 算法进行反向分析,以识别可能调节激活素 B 的候选 miRNA,激活素 B 是 ALK7 的主要配体,从而鉴定出第三个 miRNA 家族-miRNA-130/301-在肿瘤发生过程中与激活素 B 的下调相一致地上调,提示其在逃避促凋亡屏障方面具有功能参与。因此,在多步肿瘤发生和恶性进展过程中,miRNAs 的动态上调下调了肿瘤生长、侵袭和转移的独特抑制机制。